Claritev (CTEV) Asset Writedowns and Impairment (2022 - 2024)
Claritev's (CTEV) quarterly Asset Writedowns and Impairment came in at $54.5 million in Q4 2024, down 84.92% quarter-over-quarter from $361.6 million in Q3 2024.
Claritev (CTEV) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Claritev's Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $54.5 million for Q4 2024.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $54.5 million in Q4 2024; TTM through Sep 2025 was $54.5 million, a 96.2% decrease from a year earlier, with the FY2024 full-year figure at $1.5 billion, changed N/A from the prior year.
- Asset Writedowns and Impairment eased to $54.5 million in Q4 2024 per CTEV's latest filing, from $361.6 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $660.3 million in Q4 2022 and bottomed at $54.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 32.94 Bn | 25.62 Bn | 662.02 Mn |
| 2 | Healthequity | 8.59 Bn | 8.33 Bn | 256.31 Mn |
| 3 | 10x Genomics | 5.96 Bn | 5.42 Bn | 106.18 Mn |
| 4 | Hinge Health | 5.93 Bn | 5.61 Bn | 154.23 Mn |
| 5 | MiniMed | 4.56 Bn | 4.26 Bn | 480.00 Mn |
| 6 | Waystar Holding | 4.55 Bn | 4.49 Bn | 216.84 Mn |
| 7 | Doximity | 3.98 Bn | 3.23 Bn | 125.97 Mn |
| 8 | Privia Health | 3.07 Bn | 2.65 Bn | - |
| 9 | Omnicell | 1.92 Bn | 1.69 Bn | 140.36 Mn |
| 10 | Claritev | 387.60 Mn | 352.87 Mn | 175.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 54.54 Mn |
| Dec 31, 2024 | 54.54 Mn |
| Sep 30, 2024 | 361.61 Mn |
| Sep 30, 2024 | 361.61 Mn |
| Jun 30, 2024 | 553.70 Mn |
| Jun 30, 2024 | 553.70 Mn |
| Mar 31, 2024 | 519.10 Mn |
| Mar 31, 2024 | 519.10 Mn |
| Dec 31, 2022 | 660.30 Mn |
| Dec 31, 2022 | 660.30 Mn |